Impact BioMedical Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IBO research report →
Price Chart
About the company
Houston, Texas-based Impact BioMedical Inc. , founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions.
- CEO
- Frank D. Heuszel
- IPO
- 2024
- Employees
- 2
- HQ
- Houston, TX, US
Get TickerSpark's AI analysis on IBO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $52.83M
- P/E
- 30.17
- PEG
- 0.05
- P/S
- 1390.36
- P/B
- 5.16
- EV/EBITDA
- 322.03
- Div Yield
- 0.00%
- Gross Margin
- -1028.95%
- Op Margin
- -12623.68%
- Net Margin
- 4247.37%
- ROE
- 14.36%
- ROIC
- 56.37%
Latest fiscal year · YoY change
- Revenue
- $32.00K+0.0%
- Gross Profit
- $-392,000+0.0%
- Op Income
- $-4,270,000
- Net Income
- $-11,838,000+52.1%
- EPS
- $-4.80-5407.2%
- OCF Growth
- +66.5%
- FCF Growth
- +66.5%
- 52W High
- $10.51
- 52W Low
- $2.43
- 50D MA
- $4.84
- 200D MA
- $6.19
- Beta
- 2.89
- RSI (14)
- 69
- Avg Volume
- 17.43K
No earnings-call transcripts are available for IBO yet.
- Free Float
- 91.6%
- Shares Outstanding
- 8.64M
- Float Shares
- 7.91M
of shares held by institutions
20 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 814.88K | ▲ 711.98K |
| Northern Trust Corp | 235.47K | ▼ 8.47K |
| Citadel Advisors LLC | 49.57K | ▲ 49.57K |
| Two Sigma Investments, LP | 17.19K | ▼ 20.24K |
| Mason & Associates Inc | 10.00K | 0 |
| Cwm, LLC | 28 | ▲ 28 |
Held by 20 ETFs
Biggest fund positions in IBO by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 7, 26 | Suseck Mark | other | 4,170 |
| Oct 7, 26 | Zimmerman Christian Thomas | other | 4,170 |
| Oct 7, 26 | Hibbert Castel Berisford | other | 4,170 |
| Oct 7, 26 | Sims Melissa Kaye | other | 4,170 |
| Oct 7, 26 | Keene David K | other | 4,170 |
| Oct 7, 26 | Brownell Elise | other | 4,170 |
| Oct 7, 26 | Chan Heng Fai Ambrose | other | 4,170 |
| Oct 7, 26 | Grady Jason | other | 4,170 |
| Oct 7, 26 | Macko Todd D | other | 4,170 |
| Sep 22, 26 | DSS, INC. | sell | 723 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our IBO coverage
Recent articles, reports, and earnings notes.
No research on IBO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IBO report →Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley's Limited)
globenewswire.com · Sep 16
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
globenewswire.com · Sep 14
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley's Ltd.
globenewswire.com · Sep 11
Impact Biomedical Investor News: Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO
businesswire.com · Apr 12
Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO
businesswire.com · Apr 11
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
globenewswire.com · Apr 3
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
globenewswire.com · Aug 18
IBO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Impact BioMedical Inc. Is Fair to Shareholders
businesswire.com · Jun 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.